US Stock MarketDetailed Quotes
AVBP ArriVent BioPharma
- 26.730
- -0.050-0.19%
Close Aug 30 16:00 ET
897.75MMarket Cap-11965P/E (TTM)
27.440High26.350Low187.84KVolume26.780Open26.780Pre Close5.04MTurnover2.25%Turnover RatioLossP/E (Static)33.59MShares28.65052wk High3.03P/B222.75MFloat Cap14.35052wk Low--Dividend TTM8.33MShs Float28.650Historical High--Div YieldTTM4.07%Amplitude14.350Historical Low26.843Avg Price1Lot Size
ArriVent BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 13.78%25.7M | 69.85%20.67M | 102.11%74.59M | 121.39%23.12M | 42.05%16.72M | 22.58M | 12.17M | 36.91M | 10.44M | 11.77M |
| Selling and administrative expenses | 76.06%3.92M | 91.06%3.7M | 49.95%9.71M | 73.15%3.11M | 45.09%2.44M | --2.23M | --1.94M | --6.47M | --1.8M | --1.68M |
| -General and administrative expense | 76.06%3.92M | 91.06%3.7M | 49.95%9.71M | 73.15%3.11M | 45.09%2.44M | --2.23M | --1.94M | --6.47M | --1.8M | --1.68M |
| Research and development costs | 6.98%21.78M | 65.84%16.98M | 113.20%64.88M | 131.41%20.01M | 41.54%14.28M | --20.36M | --10.24M | --30.43M | --8.65M | --10.09M |
| Operating profit | -13.78%-25.7M | -69.85%-20.67M | -102.11%-74.59M | -121.39%-23.12M | -42.05%-16.72M | -22.58M | -12.17M | -36.91M | -10.44M | -11.77M |
| Net non-operating interest income expense | 275.91%3.82M | 3.26M | 5.26M | 1.93M | 2.32M | 1.02M | 0 | 0 | 0 | 0 |
| Non-operating interest income | 275.91%3.82M | --3.26M | --5.26M | --1.93M | --2.32M | --1.02M | --0 | --0 | --0 | --0 |
| Other net income (expense) | ||||||||||
| Income before tax | -1.42%-21.87M | -43.09%-17.42M | -87.86%-69.33M | -102.96%-21.19M | -22.37%-14.4M | -21.57M | -12.17M | -36.91M | -10.44M | -11.77M |
| Income tax | ||||||||||
| Net income | -1.42%-21.87M | -43.09%-17.42M | -87.86%-69.33M | -102.96%-21.19M | -22.37%-14.4M | -21.57M | -12.17M | -36.91M | -10.44M | -11.77M |
| Net income continuous Operations | -1.42%-21.87M | -43.09%-17.42M | -87.86%-69.33M | -102.96%-21.19M | -22.37%-14.4M | ---21.57M | ---12.17M | ---36.91M | ---10.44M | ---11.77M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -1.42%-21.87M | -43.09%-17.42M | -87.86%-69.33M | -102.96%-21.19M | -22.37%-14.4M | -21.57M | -12.17M | -36.91M | -10.44M | -11.77M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1.42%-21.87M | -43.09%-17.42M | -87.86%-69.33M | -102.96%-21.19M | -22.37%-14.4M | -21.57M | -12.17M | -36.91M | -10.44M | -11.77M |
| Basic earnings per share | 3.69%-0.65 | -83.78%-0.7 | -87.86%-2.1696 | -102.96%-0.6632 | -22.37%-0.4506 | -0.6749 | -0.3809 | -1.1549 | -0.3268 | -0.3682 |
| Diluted earnings per share | 3.69%-0.65 | -83.78%-0.7 | -87.86%-2.1696 | -102.96%-0.6632 | -22.37%-0.4506 | -0.6749 | -0.3809 | -1.1549 | -0.3268 | -0.3682 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg